BioNexus Gene Lab Corp - 10-Q Filing
BioNexus Gene Lab Corp filed its Q1 2026 Form 10-Q on May 15, 2026. The filing includes unaudited financial statements showing cash and bank balances of $1.3 million as of March 31, 2026 (down from $2.4 million at year-end). Fixed deposits totaled $2.6 million with some maturities exceeding three months.
Tickers: $BGLC